AusPAR: Everolimus

Australian Public Assessment Report

AusPAR

AusPAR: Everolimus [PDF, 2.16 MB]

AusPAR: Everolimus [Word, 4.59 MB]

Attachment: Product Information: Everolimus [PDF, 1.14 MB]

Attachment: Product Information: Everolimus [Word, 1.15 MB]

Attachment: Extract from Clinical Evaluation Report: Everolimus [PDF, 2.83 MB]

Attachment: Extract from Clinical Evaluation Report: Everolimus [Word, 5.84 MB]

Device/Product Name

Afinitor

Active ingredients

Everolimus

AusPAR Date

30 November 2018

Published

21 February 2019

Submission Number

PM-2016-03871-1-1

Submission Type

Major variation (new indication)

Decision

Approved